These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 17308359)

  • 1. Diagnostic value of differential expression of CK19, Galectin-3, HBME-1, ERK, RET, and p16 in benign and malignant follicular-derived lesions of the thyroid: an immunohistochemical tissue microarray analysis.
    Barroeta JE; Baloch ZW; Lal P; Pasha TL; Zhang PJ; LiVolsi VA
    Endocr Pathol; 2006; 17(3):225-34. PubMed ID: 17308359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultrasound Risk Assessment Combined with Molecular Markers of Galectin-3, c-MET, HBME-1 and CK19 for Diagnosis of Malignant and Benign Thyroid Nodules.
    Han RL; Wang J; Zhang FJ; Zhao N; Gao BL
    Pathol Oncol Res; 2019 Jul; 25(3):1075-1081. PubMed ID: 30361909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic significance of CK19, RET, galectin-3 and HBME-1 expression for papillary thyroid carcinoma.
    Zhu X; Sun T; Lu H; Zhou X; Lu Y; Cai X; Zhu X
    J Clin Pathol; 2010 Sep; 63(9):786-9. PubMed ID: 20644217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical diagnosis of papillary thyroid carcinoma.
    Cheung CC; Ezzat S; Freeman JL; Rosen IB; Asa SL
    Mod Pathol; 2001 Apr; 14(4):338-42. PubMed ID: 11301350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical expression of HBME-1 and galectin-3 in the differential diagnosis of follicular-derived thyroid nodules.
    Abd-El Raouf SM; Ibrahim TR
    Pathol Res Pract; 2014 Dec; 210(12):971-8. PubMed ID: 25041837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic value of galectin-3, HBME-1, cytokeratin 19, high molecular weight cytokeratin, cyclin D1 and p27(kip1) in the differential diagnosis of thyroid nodules.
    Park YJ; Kwak SH; Kim DC; Kim H; Choe G; Park DJ; Jang HC; Park SH; Cho BY; Park SY
    J Korean Med Sci; 2007 Aug; 22(4):621-8. PubMed ID: 17728499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential expression of galectin-3, CK19, HBME1, and Ret oncoprotein in the diagnosis of thyroid neoplasms by fine needle aspiration biopsy.
    Saleh HA; Feng J; Tabassum F; Al-Zohaili O; Husain M; Giorgadze T
    Cytojournal; 2009 Sep; 6():18. PubMed ID: 19826479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic value of TROP-2 expression in papillary thyroid carcinoma and comparison with HBME-1, galectin-3 and cytokeratin 19.
    Murtezaoglu AR; Gucer H
    Pol J Pathol; 2017; 68(1):1-10. PubMed ID: 28547974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expression of cytokeratin19, galectin-3 and HBME-1 in thyroid lesions and their differential diagnoses].
    Teng XD; Wang LJ; Yao HT; Li J; Ding W; Yan LP
    Zhonghua Bing Li Xue Za Zhi; 2004 Jun; 33(3):212-6. PubMed ID: 15256110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defining the value of CD56, CK19, Galectin 3 and HBME-1 in diagnosis of follicular cell derived lesions of thyroid with systematic review of literature.
    Dunđerović D; Lipkovski JM; Boričic I; Soldatović I; Božic V; Cvejić D; Tatić S
    Diagn Pathol; 2015 Oct; 10():196. PubMed ID: 26503236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Universal markers of thyroid malignancies: galectin-3, HBME-1, and cytokeratin-19.
    Barut F; Onak Kandemir N; Bektas S; Bahadir B; Keser S; Ozdamar SO
    Endocr Pathol; 2010 Jun; 21(2):80-9. PubMed ID: 20198455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expression of GADD153 in follicular tumors of thyroid and comparison with CK19, Galectin-3 and HBME-1].
    Tang QS; Teng XD; Ding W; Zhou J; Yao HT; Ying LX; Xu LM
    Zhonghua Bing Li Xue Za Zhi; 2011 Nov; 40(11):745-8. PubMed ID: 22336157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential diagnostic significance of HBME-1, CK19 and S100 in various thyroid lesions.
    Palo S; Biligi DS
    Malays J Pathol; 2017 Apr; 39(1):55-67. PubMed ID: 28413206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of immunohistochemical markers in differentiating benign from malignant follicular-derived thyroid nodules.
    Saleh HA; Jin B; Barnwell J; Alzohaili O
    Diagn Pathol; 2010 Jan; 5():9. PubMed ID: 20181018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined immunohistochemistry for thyroid peroxidase, galectin-3, CK19 and HBME-1 in differential diagnosis of thyroid tumors.
    Paunovic I; Isic T; Havelka M; Tatic S; Cvejic D; Savin S
    APMIS; 2012 May; 120(5):368-79. PubMed ID: 22515291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous immunohistochemical expression of HBME-1 and galectin-3 differentiates papillary carcinomas from hyperfunctioning lesions of the thyroid.
    Rossi ED; Raffaelli M; Mule' A; Miraglia A; Lombardi CP; Vecchio FM; Fadda G
    Histopathology; 2006 Jun; 48(7):795-800. PubMed ID: 16722927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Challenge in the Pathological Diagnosis of the Follicular- Patterned Thyroid Lesions.
    Elsers DA; Hussein MRA; Osman MH; Mohamed GA; Hosny G
    Asian Pac J Cancer Prev; 2021 Oct; 22(10):3365-3376. PubMed ID: 34711014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic value of HBME-1, CK19, Galectin 3, and CD56 in the subtypes of follicular variant of papillary thyroid carcinoma.
    Cho H; Kim JY; Oh YL
    Pathol Int; 2018 Nov; 68(11):605-613. PubMed ID: 30350394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expression of TTF-1 in thyroid tumors originating from follicular epithelium and its correlation with expression of RET, galectin-3 and mucin-1 genes].
    Chen Y; Zhu M; Zhou X; Lin W; Ni C; Li F; Zhang S; Gong Z
    Zhonghua Yi Xue Za Zhi; 2002 Feb; 82(4):257-61. PubMed ID: 11953175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined immunostaining with galectin-3, fibronectin-1, CITED-1, Hector Battifora mesothelial-1, cytokeratin-19, peroxisome proliferator-activated receptor-{gamma}, and sodium/iodide symporter antibodies for the differential diagnosis of non-medullary thyroid carcinoma.
    Liu YY; Morreau H; Kievit J; Romijn JA; Carrasco N; Smit JW
    Eur J Endocrinol; 2008 Mar; 158(3):375-84. PubMed ID: 18299472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.